Page last updated: 2024-08-17

mepenzolate bromide and Airflow Obstruction, Chronic

mepenzolate bromide has been researched along with Airflow Obstruction, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, T; Fukunishi, Y; Hanaya, K; Ishihara, T; Kobayashi, D; Mashimo, T; Mizushima, T; Shoji, M; Sugai, T; Tanaka, K; Wada, M; Yamakawa, N; Yamashita, Y1

Other Studies

1 other study(ies) available for mepenzolate bromide and Airflow Obstruction, Chronic

ArticleYear
Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.
    Bioorganic & medicinal chemistry, 2014, Jul-01, Volume: 22, Issue:13

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzilates; Bronchodilator Agents; Dose-Response Relationship, Drug; Heart Rate; Male; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Piperidines; Pulmonary Disease, Chronic Obstructive; Receptor, Muscarinic M3; Stereoisomerism; Structure-Activity Relationship

2014